{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:35:25Z","timestamp":1792715725342,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100021136","name":"Indian Institute of Technology Hyderabad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017604","name":"National Institute of Technology Warangal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017604","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bioorg.2026.109711","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:32:30Z","timestamp":1772670750000},"page":"109711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Synthesis and anti-lung cancer evaluation of fused pyrazolo[3,4-b]pyridine linked isoxazoles and 1,2,3-triazoles: PEG-400 mediated one-pot reaction under microwave irradiation"],"prefix":"10.1016","volume":"174","author":[{"given":"G.","family":"Jyothi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rambabu","family":"Palabindela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravikumar","family":"Kapavarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar","family":"Kavela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirassu","family":"Narsimha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2026.109711_bb0005","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.109711_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140625","article-title":"Synthesis and in vitro cytotoxic evaluation of pyrazolo[1,5-c]quinazoline-triazole conjugates","volume":"1322","author":"Talebian","year":"2025","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109711_bb0015","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.109711_bb0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13027-016-0110-9","article-title":"African Organization for Research and Training in Cancer: position and vision for cancer research on the African continent","volume":"11","author":"Ogunbiyi","year":"2016","journal-title":"Infect Agents Cancer."},{"key":"10.1016\/j.bioorg.2026.109711_bb0025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrc1295","article-title":"Dynamics of cancer progression","volume":"4","author":"Michor","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2026.109711_bb0030","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2026.109711_bb0035","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Eastern cooperative oncology group, comparison of four chemotherapy regimens for advanced non\u2013small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2026.109711_bb0040","article-title":"Emerging import ance of tyrosine kinase inhibitors against cancer: quo vadis to cure?","volume":"22","author":"Mongre","year":"2021","journal-title":"Int J Molecul Sc."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109711_bb0045","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1080\/14756366.2022.2112575","article-title":"Discovery of new 1 H-pyrazolo[3,4- d]pyrimidine derivatives as anticancer agents targeting EGFRWT and EGFRT790M","volume":"37","author":"Gaber","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109711_bb0050","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0092-8674(00)00114-8","article-title":"Cell signaling by receptor tyrosine kinases","volume":"103","author":"Schlessinger","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2026.109711_bb0055","first-page":"1","article-title":"Exploring receptor tyrosine kinases-inhibitors in Cancer treatments","volume":"20","author":"Metibemu","year":"2019","journal-title":"Egyptian J Med Human Genet."},{"key":"10.1016\/j.bioorg.2026.109711_bb0060","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.3390\/ijms19113491","article-title":"Receptor tyrosine kinase-targeted cancer therapy","volume":"19","author":"Yamaoka","year":"2018","journal-title":"Int J Molecul Sci."},{"key":"10.1016\/j.bioorg.2026.109711_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-018-0797-x","article-title":"Receptor tyrosine kin ases (RTKs) in breast cancer: signaling, therapeutic implications and challenges","volume":"17","author":"Butti","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2026.109711_bb0070","doi-asserted-by":"crossref","unstructured":"M. A.Olayioye, R.M.Neve, H.A.Lane, NEHynes. The ErbB signal ing network: receptor heterodimerization in development and cancer. EMBO J. 19 (2000) 3159\u20133167. https:\/\/doi.org\/10.1093\/emboj\/19.13.3159.","DOI":"10.1093\/emboj\/19.13.3159"},{"key":"10.1016\/j.bioorg.2026.109711_bb0075","doi-asserted-by":"crossref","unstructured":"M.L.de Castro Barbosa, L.M.Lima, R.Tesch, C. M. R. Sant'Anna, F. Totzke, M.H. G.Kubbutat, C.Sch\u00e4chtele, S. A. Laufer, E. J. Barreiro, Novel 2 chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR 2 dual inhibitors. Eur. J. Med. Chem. 71 (2014) 1\u201314. Doi: https:\/\/doi.org\/10.1016\/j.ejmech.2013.10.058.","DOI":"10.1016\/j.ejmech.2013.10.058"},{"key":"10.1016\/j.bioorg.2026.109711_bb0080","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ejmech.2017.07.005","article-title":"Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro","volume":"138","author":"Chang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109711_bb0085","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ejmech.2017.08.035","volume":"139","author":"Chen","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109711_bb0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0959-8049(01)00231-3","article-title":"EGFR and cancer prognosis","volume":"37","author":"Nicholson","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bioorg.2026.109711_bb0095","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejmech.2016.09.039","article-title":"Design and discovery of 4-anilinoquinazoline-urea derivatives as dual TK inhibitors of EGFR and VEGFR-2","volume":"125","author":"Zhang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109711_bb0100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ejmech.2017.03.083","article-title":"Synthesis and biological evaluation of morpholine-substituted diphenylpyrimidinederivatives (Mor-DPPYs) as potent EGFR T790M inhibitors with improved activity toward the gefitinib-resistant non-small cell lung cancers (NSCLC)","volume":"133","author":"Song","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109711_bb0105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejmech.2018.01.090","article-title":"6, 7-Dimorpholinoalkoxy quinazoline derivatives as potent EGFR inhibitors with enhanced antiproliferative activities against tumor cells","volume":"147","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109711_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102985","article-title":"Synthesis and in vitro anticancer evaluation of some fused indazoles, quinazolines and quinolines as potential EGFR inhibitors","volume":"89","author":"Abdelsalam","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109711_bb0115","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ejmech.2018.06.024","article-title":"Novel series of 6-(2-substitutedacetamido)-4-anilinoquinazolines as EGFR ERK signal transduction inhibitors in MCF-7 breast cancer cells","volume":"155","author":"Ismail","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109711_bb0120","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1517\/13543784.12.8.1395","article-title":"Erlotinib: a new therapeutic approach for non-small cell lung cancer","volume":"12","author":"Bonomi","year":"2003","journal-title":"Expert OpinInvestigat Drugs."},{"key":"10.1016\/j.bioorg.2026.109711_bb0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.clae.2014.08.005","article-title":"Ocular side effects and trichomegaly of eyelashes induced by erlotinib: a case report and review of the literature","volume":"38","author":"Celik","year":"2015","journal-title":"Contact Lens Anterior Eye."},{"key":"10.1016\/j.bioorg.2026.109711_bb0130","series-title":"Gefitinib","author":"Muhsin","year":"2003"},{"key":"10.1016\/j.bioorg.2026.109711_bb0135","article-title":"Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain","volume":"2","author":"Pao","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.bioorg.2026.109711_bb0140","unstructured":"U.S. Food & Drug Administration. FDA approves neratinib for extended adjuvant treatment of early stage HER2-positive breast cancer. 2017."},{"key":"10.1016\/j.bioorg.2026.109711_bb0145","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1200\/JCO.2009.27.9414","article-title":"Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non\u2013small-cell lung cancer","volume":"28","author":"Sequist","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2026.109711_bb0150","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1158\/1535-7163.MCT-11-0750","article-title":"The EGFR T790M mutation in acquired resistance to an irreversible second-generation EGFR inhibitor","volume":"11","author":"Kim","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioorg.2026.109711_bb0155","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMoa1411817","article-title":"AZD9291 in EGFR inhibitor\u2013resistant non\u2013small-cell lung cancer","volume":"372","author":"J\u20ac anne","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2026.109711_bb0160","unstructured":"J. Carroll, Following lethal tox report, Boehringer scraps plans for high-speed development, kills $730M Hanmi deal. 2019. https:\/\/endpts.com\/following-lethal-tox-report-boehringer scraps-plans-for-high-speed-development-kills-730m-hanmi deal\/."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109711_bb0165","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acsmedchemlett.6b00066","article-title":"Discovery of substituted 1H-pyrazolo[3,4-b]pyridine derivatives as potent and selective FGFR kinase inhibitors","volume":"7","author":"Zhao","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109711_bb0170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00044-023-03161-4","article-title":"One-pot synthesis and in vitro bioactivity of novel 4-aminopyrazolo[3,4-b]pyridine derivatives as potential antimicrobial compounds","volume":"33","author":"Aggarwal","year":"2024","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2026.109711_bb0175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00044-020-02656-8","article-title":"Pyrimidine and fused pyrimidine derivatives as promising protein kinase inhibitors for cancer treatment","volume":"30","author":"Abdellatif","year":"2021","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2026.109711_bb0180","doi-asserted-by":"crossref","unstructured":"J. L.Ribeiro, J. C.Soares, G. B.Portapilla, M. V.Providello, C. H.Lima, E. M.Muri, S.de Albuquerque, L. R. Dias,Trypanocidal activity of new 1,6-diphenyl-1H-pyrazolo[3,4-b]pyridine derivatives: synthesis, in vitro and in vivo studies. Bioorg. Med. Chem. 29 (2021) 115855.Doi: https:\/\/doi.org\/10.1016\/j.bmc.2020.115855.","DOI":"10.1016\/j.bmc.2020.115855"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109711_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jksus.2021.101767","article-title":"Pyrazolo[3,4 b]pyridin-3(2H)-one derivatives: synthesis and their investigation of mosquito larvicidal activity","volume":"34","author":"Al-Zharani","year":"2022","journal-title":"J. King Saud Univ., Sci."},{"issue":"17","key":"10.1016\/j.bioorg.2026.109711_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28176428","article-title":"Synthesis and in vitro anticancer activity of novel 4 aryl-3-(4-methoxyphenyl)-1- phenyl-1H-pyrazolo[3,4-b]pyridinesAr rest cell cycle and induce cell apoptosis by inhibiting CDK2 and\/or CDK9","volume":"28","author":"Almansour","year":"2023","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bioorg.2026.109711_bb0195","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1007\/s13738-022-02568-x","article-title":"Expeditious microwavable one-pot synthesis and biological exploration of spiro[indoline-3,4\u2032-pyrazolo[3,4-b]]pyridine derivatives","volume":"19","author":"Naglaa","year":"2022","journal-title":"J. Iran. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.109711_bb0200","series-title":"N-Heterocycles: Synthesis and Biological Evaluation","first-page":"143","article-title":"Synthesis and biological importance of Pyrazole, Pyrazoline, and Indazole as antibacterial, antifungal, Antitubercular, anticancer, and anti-inflammatory agents","author":"Desai","year":"2022"},{"issue":"8","key":"10.1016\/j.bioorg.2026.109711_bb0205","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/jhet.4691","article-title":"Synthesis of anthracene linked polycyclic pyridine derivatives fused with coumarin and pyrazole by one pot multi-component strategy followed by oxidation","volume":"60","author":"Mehar","year":"2023","journal-title":"J. Heterocyclic Chem."},{"issue":"19","key":"10.1016\/j.bioorg.2026.109711_bb0210","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.3390\/molecules27196381","article-title":"Synthesis of diversified Pyrazolo[3,4-b]pyridine frame works from 5- Aminopyrazoles and Alkynyl aldehydes via switchable C\u2261C bond activation approaches","volume":"27","author":"Miao","year":"2022","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.bioorg.2026.109711_bb0215","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3109\/00498258109045858","article-title":"Biotransformation in the monkey of cartazolate(SQ 65,396), a substituted pyrazolopyridine having anxiolytic activity","volume":"11","author":"Kripalani","year":"1981","journal-title":"Xenobiotica"},{"issue":"12","key":"10.1016\/j.bioorg.2026.109711_bb0220","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1021\/jm00132a011","article-title":"Synthesis and structure-activity relationships of a series of anxioselectivepyrazolopyridine ester and amide anxiolytic agents","volume":"32","author":"Bare","year":"1989","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109711_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117614","article-title":"1,5-Disubstituted 1,2,3-triazoles: molecular scaffolds for medicinal chemistry and biomolecular mimetics","volume":"291","author":"Mishra","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109711_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115254","article-title":"Recent updates on 1,2,3-triazole-containing hybrids with in vivo therapeutic potential against cancers: a mini-review","volume":"251","author":"Zhao","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109711_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115603","article-title":"Recent advances in 1,2,3- and 1,2,4-triazole hybrids as antimicrobials and their SAR: a critical review","volume":"259","author":"Tian","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109711_bb0240","article-title":"Fused benzo [1,3]thiazine-1,2,3-triazole hybrids: microwave-assisted one-pot synthesis, in vitro antibacterial, antibiofilm, and in silico ADME studies","volume":"47","author":"Sucharitha","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"26","key":"10.1016\/j.bioorg.2026.109711_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202300777","article-title":"Fused imidazo[2,1-b][1,2,3]triazolo[4,5-d][1,3]thiazines: one-pot synthesis, antibiofilim, bactericidal effects, and in silico studies","volume":"8","author":"Ramu","year":"2023","journal-title":"ChemistrySelect"},{"issue":"20","key":"10.1016\/j.bioorg.2026.109711_bb0250","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1002\/slct.202100442","article-title":"Progress in the synthesis of fused 1,2,3-Triazoles","volume":"6","author":"Kumar","year":"2021","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2026.109711_bb0255","article-title":"The current landscape of 1,2,3-triazole-(fused) six-membered nitrogen-containing heteroaromatic ring hybrids with anticancer therapeutic potential","volume":"358","author":"Xu","year":"2025","journal-title":"Arch Pharm (Weinheim)"},{"issue":"6","key":"10.1016\/j.bioorg.2026.109711_bb0260","article-title":"Synthesis and biological evaluation of benzo[d]thiazolyl-sulfonyl-benzo[4,5]isothiazolo [2,3-c][1,2,3] triazole derivatives as EGFR targeting anticancer agents","volume":"8","author":"Sucharitha","year":"2023","journal-title":"ChemistrySelect"},{"issue":"43","key":"10.1016\/j.bioorg.2026.109711_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202203388","article-title":"Cu(I)- catalyzed one-pot synthesis of [1,2,3]triazolo[5,1-a] isoquinolin-6(5H)-one derivatives as EGFR-targeting anticancer agents","volume":"7","author":"Samala","year":"2022","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2026.109711_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134378","article-title":"Synthesis and biological evaluation of novel [1,2,3]triazolo-pyrrolo [1,2-a]pyrido[4,3-d]pyrimidines as EGFR targeting anticancer agents","volume":"1274","author":"Bandi","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109711_bb0275","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/jhet.4788","article-title":"Synthesis of novel [1,2,3]triazolo[4,5\u2032 :3,4]pyrrolo[1,2-a]thieno[2,3-d] pyrimidines: potent EGFR targeting anti-breast cancer agents","volume":"61","author":"Samala","year":"2024","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.bioorg.2026.109711_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139570","article-title":"One- pot synthesis, anticancer, EGFR and caspases assays of novel fused [1,2,3] triazolo-pyrrolo [2,1-b] quinazolinones","volume":"1320","author":"Udayasree","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109711_bb0285","article-title":"Synthesis and biological evaluation of pyrido[3,2,1-Ij][1,2,3]triazolo[4,5-c] quinolinones: PEG- 400 mediated one-pot reaction under ultrasonic irradiation","author":"Johnpasha","year":"2023","journal-title":"Polycycl. Aromat. Compd."},{"key":"10.1016\/j.bioorg.2026.109711_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138440","article-title":"Synthesis and anti-breast cancer evaluation of fused imidazole-imidazo [1,2-c][1,2,3]triazoles: PEG-400 mediated one-pot reaction under ultrasonic irradiation","volume":"1312","author":"Johnpasha","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109711_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135944","article-title":"Synthesis and biological evaluation of coumarine-imidazo[1,2-c][1,2,3]triazoles: PEG-400 mediated one-pot reaction under ultrasonic irradiation","volume":"1290","author":"Samala","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"40","key":"10.1016\/j.bioorg.2026.109711_bb0300","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202402970","article-title":"One-pot synthesis of fused Isoxazolo[4\u2032,5\u2032:3,4]pyrrolo[2,1-b] Quinazolines as potent EGFR targeting anticancer agents","volume":"9","author":"Lavunuri","year":"2024","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2026.109711_bb0305","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1016\/j.bmc.2012.06.002","article-title":"Design, synthesis, biochemical studies, cellular characterization, and structure-based computational studies of small molecules targeting the urokinase receptor","volume":"20","author":"Wang","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109711_bb0310","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202302584","article-title":"Synthesis of fused Isoxazoles of Iodoquinol as in\u00a0vitro EGFR aiming anticancer agents","volume":"9","author":"Bokkala","year":"2024","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2026.109711_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.tetlet.2025.155570","article-title":"Microwave-assisted one-pot synthesis of fused isoxazolo[4\u2032,5\u2032:3,4]pyrrolo[1,2-c]pyrimidines as potent anticancer agents: in vitro and in silico study","volume":"162","author":"Thatikonda","year":"2025","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2026.109711_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.tetlet.2024.155325","article-title":"One-pot synthesis of fused isoxazolo[4\u2032,5\u2032:4,5] thiopyrano[2,3-d]pyrimidines as potent EGFR targeting anti-lung cancer agents","volume":"151","author":"Ardhapure","year":"2024","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2026.109711_bb0325","doi-asserted-by":"crossref","unstructured":"A. Hoz, A. D\u00edaz-Ortiz, A. Moreno, Microwaves in organic synthesis. Thermal and non-thermal microwave effects, Chem. Soc. Rev. 34 (2005) 164\u2013178, https:\/\/doi. org\/https:\/\/doi.org\/10.1039\/B411438H.","DOI":"10.1039\/B411438H"},{"key":"10.1016\/j.bioorg.2026.109711_bb0330","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ultsonch.2016.10.010","article-title":"Recent developments on ultrasound-assisted one-pot multicomponent synthesis of biologically relevant heterocycles","volume":"35","author":"Banerjee","year":"2017","journal-title":"Ultrason. Sonochem."},{"key":"10.1016\/j.bioorg.2026.109711_bb0335","article-title":"Synthesis of environmentally benign new ionic liquids for the preparation of 2-aryl\/heteroaryl benzimidazoles\/benzoxazoles under ultrasonication","volume":"30","author":"Indira","year":"2022","journal-title":"Sustain. Chem. Pharm."},{"key":"10.1016\/j.bioorg.2026.109711_bb0340","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1039\/b805985c","article-title":"Improved chemoselective, ecofriendly conditions for the conversion of primary alkyl halides into nitroalkanes under PEG400","volume":"10","author":"Ballini","year":"2008","journal-title":"Green Chem."},{"key":"10.1016\/j.bioorg.2026.109711_bb0345","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1039\/b702311a","article-title":"PEG-assisted solvent and catalyst free synthesis of 3,4-dihydropyrimidinones under mild reaction conditions","volume":"9","author":"Suman","year":"2007","journal-title":"Green Chem."},{"key":"10.1016\/j.bioorg.2026.109711_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.142569","article-title":"Microwave assisted one-pot synthesis of novel 1,3,4-oxadiazole-imidazo[1\u2032,5\u2032:1,2]pyrrolo[3,4-d][1,2,3]triazoles as potent EGFR targeting anticancer agents","volume":"1341","author":"Johnpasha","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109711_bb0355","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1021\/ol070697u","article-title":"Direct Pd-catalyzed Arylation of 1,2,3-Triazoles","volume":"9","author":"Chuprakov","year":"2007","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2026.109711_bb0360","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/adsc.200800016","article-title":"Palladium-catalyzed direct Arylations of 1,2,3-Triazoles with aryl chlorides using conventional heating","volume":"350","author":"Ackermann","year":"2008","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.bioorg.2026.109711_bb0365","doi-asserted-by":"crossref","first-page":"74332","DOI":"10.1039\/C6RA12285J","article-title":"One-pot synthesis of fused benzoxazino[1,2,3]triazolyl[4,5-c]quinolinone derivatives and their anticancer activity","volume":"6","author":"Narsimha","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.109711_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134174","article-title":"The Pd(0) and Pd(II) SBA-TU-anchored catalysts in the Mizoroki-heck and Suzuki-Miyaura cross-coupling reactions: a comparative catalytic study","volume":"1273","author":"Beiranvand","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109711_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.tetlet.2022.154270","article-title":"Pd-catalyzed heteroannulation of isoxazoles: convergent synthesis of isoxazolo[5,4-c]quinolines","volume":"114","author":"Galenko","year":"2023","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2026.109711_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136451","article-title":"Synthesis of novel pyrido[2,3-d]pyrimidine-thiazolidine-1,2,3-triazoles: potent EGFR targeting anticancer agents","volume":"1294","author":"Bandi","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109711_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.137803","article-title":"Synthesis of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazine-1,2,3-triazoles as potent EGFR targeting anti-breast cancer agents","volume":"1306","author":"Chirra","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109711_bb0390","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202500049","article-title":"Synthesis of quinazoline-1,3,4-oxadiazole linked 1,2,3-triazole hybrids as potent EGFR targeting antilung cancer agents: in vitro, in silico, and DFT studies","volume":"10","author":"S.Peddapelli","year":"2025","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2026.109711_bb0395","article-title":"Organocatalytic [3+2] cycloaddition reaction: synthesis of fully decorated sulfonyl 1,2,3-Triazoles as potent EGFRTargeting anticancer agents","volume":"8","author":"Dodlapati","year":"2023","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2026.109711_bb0400","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/BJ20121513","article-title":"Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain","volume":"448","author":"Park","year":"2012","journal-title":"Biochem. J."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109711_bb0405","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1002\/jhet.4905","article-title":"Organocatalytic[3+2]cycloaddition: synthesis of Quinazoline containing sulfonyl 1,2,3-Triazoles as potent EGFR targeting anti-breast Cancer agents","volume":"61","author":"Dodlapati","year":"2024","journal-title":"J. Heterocyclic Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2026.109711_bb0410","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109711_bb0415","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A BOILED-egg to predict gastrointestinal absorption and brain penetration of small molecules","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826002476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826002476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:48:37Z","timestamp":1774860517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826002476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":83,"alternative-id":["S0045206826002476"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109711","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and anti-lung cancer evaluation of fused pyrazolo[3,4-b]pyridine linked isoxazoles and 1,2,3-triazoles: PEG-400 mediated one-pot reaction under microwave irradiation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109711","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109711"}}